Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds

Journal of Controlled Release

Volumn 112, Issue 2, 2006, Pages 249-256

  Kushibiki, Toshihiro ^a   Tomoshige, Ryuji ^a,b   Iwanaga, Kazunori ^b   Kakemi, Masawo ^b   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cationized gelatin hydrogel; Controlled release; Gene expression; Hydrogel degradation; Plasmid DNA

Indexed keywords

ALDEHYDES; AMINES; BIODEGRADATION; GENETIC ENGINEERING; HYDROGELS; MUSCLE; PROTEINS;

CATIONIZED GELATIN HYDROGEL; CONTROLLED RELEASE; GENE EXPRESSION; HYDROGEL DEGRADATION; PLASMID DNA;

DNA;

AMINE; BETA GALACTOSIDASE; CATION; DRUG CARRIER; ETHYLENEDIAMINE; GELATIN; GLUTARALDEHYDE; IODINE 125; PLASMID DNA; PUTRESCINE; SPERMIDINE; SPERMINE; WATER; DNA; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG ACTIVITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; FEMUR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYDROGEL; IMPLANTATION; IN VIVO STUDY; IONIZATION; ISOTOPE LABELING; LEG MUSCLE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RADIOACTIVITY; SUSTAINED DRUG RELEASE; TIMED DRUG RELEASE; WATER CONTENT; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG IMPLANT; GENE EXPRESSION; GENETICS; LACTOSE OPERON; METABOLISM; MOUSE STRAIN; PLASMID; SKELETAL MUSCLE;

AMINES; ANIMALS; CATIONS; DELAYED-ACTION PREPARATIONS; DNA; DRUG IMPLANTS; GELATIN; GENE EXPRESSION; HYDROGELS; INTERLEUKIN-1; LAC OPERON; MICE; MICE, INBRED STRAINS; MUSCLE, SKELETAL; PLASMIDS;

EID: 33745634172     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.02.003     Document Type: Article

References (32)

1. Curiel D.T., Gerritsen W.R., and Krul M.R. Progress in cancer gene therapy. Cancer Gene Ther. 7 (2000) 1197-1199
2. Fischer A., Hacein-Bey S., Le Deist F., Soudais C., Di Santo J.P., de Saint Basile G., and Cavazzana-Calvo M. Gene therapy of severe combined immunodeficiencies. Immunol. Rev. 178 (2000) 13-20
3. Romano G., Michell P., Pacilio C., and Giordano A. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18 (2000) 19-39
4. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat. Biotechnol. 18 (2000) 33-37
5. Anwer K., Kao G., Proctor B., Anscombe I., Florack V., Earls R., Wilson E., McCreery T., Unger E., Rolland A., and Sullivan S.M. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7 (2000) 1833-1839
6. Hossein H., Aoyama T., Ogawa O., and Tabata Y. Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin. J. Drug Target. 10 (2002) 193-204
7. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16 (1998) 867-870
8. Luo D., Woodrow-Mumford K., Belcheva N., and Saltzman W.M. Controlled DNA delivery systems. Pharm. Res. 16 (1999) 1300-1308
9. Ochiya T., Takahama Y., Nagahara S., Sumita Y., Nishida A., Itoh H., Nagai Y., and Terada M. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat. Med. 5 (1999) 707-710
10. Kushibiki T., and Tabata Y. A new gene delivery system based on controlled release technology. Curr. Drug Deliv. 1 (2004) 153-163
11. Kushibiki T., Matsumoto K., Nakamura T., and Tabata Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther. 11 (2004) 1205-1214
12. Tabata Y., Nagano A., and Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5 (1999) 127-138
13. Tabata Y., and Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20 (1999) 2169-2175
14. Fukunaka Y., Iwanaga K., Morimoto K., Kakemi M., and Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J. Control. Release 80 (2001) 333-343
15. Murphy W.L., and Mooney D.J. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J. Periodontal Res. 34 (1999) 413-419
16. Shea L.D., Smiley E., Bonadio J., and Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17 (1999) 551-554
17. Bonadio J. Tissue engineering via local gene delivery. J. Mol. Med. 78 (2000) 303-311
18. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5 (1999) 753-759
19. Kushibiki T., and Tabata Y. In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds. J. Biomater. Sci. Polym. Ed. 16 (2005) 1447-1461
20. In: Tsuruta T., Hayashi T., Kataoka K., Ishihara K., and Kimura Y. (Eds). Biomedical Applications of Polymeric Materials (1993), CRC, Boca Raton, FL
21. Van Der Valk P., Van Pelt A.W.J., Busscher H.J., De Jong H.P., Wildevuur C.R.H., and Arends J. Interaction of fibroblasts and polymer surfaces: relationship between surface free energy and fibroblast spreading. J. Biomed. Mater. Res. 17 (1983) 807-817
22. Groth T.H., Zlatanov I., and Altankov G. Adhesion of human peripheral lymphocytes on biomaterials preadsorbed with fibronectin and vitronectin. J. Biomater. Sci., Polym. Ed. 6 (1994) 729-739
23. Calvert J.W., Marra K.G., Cook L., Kumta P.N., DiMilla P.A., and Weiss L.E. Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J. Biomed. Mater. Res. 52 (2000) 279-284
24. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652
25. Tabata Y., and Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophages. Biomaterials 9 (1988) 356-362
26. Bonfield T.L., Colton E., Marchant R.E., and Anderson J.M. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J. Biomed. Mater. Res. 26 (1992) 837-850
27. Bonfield T.L., and Anderson J.M. Functional versus quantitative comparison of IL-1β from monocytes/macrophages on biomedical polymers. J. Biomed. Mater. Res. 27 (1993) 1195-1199
28. Cardona M.A., Simmons R.L., and Kaplan S.S. TNF and IL-1 generation by human monocytes in response to biomaterials. J. Biomed. Mater. Res. 26 (1992) 851-859
29. Jenny C.R., and Anderson J.M. Alkylsilane-modified surfaces: inhibition of human macrophage adhesion and foreign body giant cell formation. J. Biomed. Mater. Res. 46 (1999) 11-21
30. 2 by human mononuclear cells in vitro. Biomaterials 21 (2000) 1047-1055
31. Matthews J.B., Besong A.A., Green T.R., Stone M.H., Wroblewski B.M., Fisher J., and Ingham E. Evaluation of the response of primary human peripheral blood mononuclear phagocytes to challenge with in vitro generated clinically relevant UHMWPE particles of known size and dose. J. Biomed. Mater. Res. 52 (2000) 296-307
32. Nakaoka R., Inoue Y., Tabata Y., and Ikada Y. Size effect on the antibody production induced by biodegradable microspheres containing antigen. Vaccine 14 (1996) 1251-1256